Target Validation Information
TTD ID	T48069
Target Name	Insulin-like growth factor I receptor (IGF1R)
Type of Target	Successful
Drug Potency against Target	AEW-541	Drug Info	IC50 = 86 nM	[5]
	4-((1H-indazol-6-ylamino)methyl)benzene-1,2-diol	Drug Info	IC50 = 1500 nM	[1]
	4-((naphthalen-2-ylamino)methyl)benzene-1,2-diol	Drug Info	IC50 = 4500 nM	[1]
	BMS-536924	Drug Info	IC50 = 100 nM	[3]
	BMS-695735	Drug Info	IC50 = 34 nM	[2]
	OSI-906	Drug Info	IC50 = 18 nM	[4]
References
REF 1	ATP non-competitive IGF-1 receptor kinase inhibitors as lead anti-neoplastic and anti-papilloma agents. Eur J Pharmacol. 2007 May 7;562(1-2):1-11.
REF 2	Discovery and evaluation of 4-(2-(4-chloro-1H-pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1H-benzo[d]imidazol-2-yl)py... J Med Chem. 2008 Oct 9;51(19):5897-900.
REF 3	SAR of PXR transactivation in benzimidazole-based IGF-1R kinase inhibitors. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1744-8.
REF 4	Imidazo[2,1-b]thiazoles: multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family... Bioorg Med Chem Lett. 2010 Apr 15;20(8):2452-5.
REF 5	In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase. Cancer Cell. 2004 Mar;5(3):231-9.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.